Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
0.6246
+0.0296 (4.97%)
At close: Jan 7, 2026, 4:00 PM EST
0.6200
-0.0046 (-0.74%)
After-hours: Jan 7, 2026, 7:52 PM EST
Femasys Market Cap
Femasys has a market cap or net worth of $37.09 million as of January 7, 2026. Its market cap has increased by 49.98% in one year.
Market Cap
37.09M
Enterprise Value
39.19M
1-Year Change
49.98%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $37.09M, a decrease of -75.74%. That is a compound annual growth rate of -26.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 35.33M | 3.26% |
| Dec 31, 2025 | 34.22M | 35.85% |
| Dec 31, 2024 | 25.19M | 19.33% |
| Dec 29, 2023 | 21.11M | 98.53% |
| Dec 30, 2022 | 10.63M | -76.90% |
| Dec 31, 2021 | 46.02M | -69.90% |
| Jun 18, 2021 | 152.90M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |